Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Spanier, BW Marcel"'
Autor:
van Heukelem Henk A, Cense Huib A, van Berkel Anne-Marie, Bilgen Ernst, Spanier BW Marcel, Stassen Laurents PS, Bolwerk Clemens JM, Gerhards Michael F, Jansen Jeroen M, Marinelli Andreas WKS, van der Werf Sjoerd DJ, Consten Esther CJ, Brink Menno A, Stockmann Henricus B, Marsman Willem A, Prins Hubert A, van Ditzhuijsen Theo JM, Pierik Robert EGJM, Vecht Juda, Houben Martin HMG, van der Zaag Edwin S, Lieverse Rob J, Boom Maarten J, Mallant Rosalie C, Lange Johan, van der Woude C Janneke, Davids Paul HP, Voorburg Annet MCJ, Sosef Meindert N, Oostenbrug Liekele E, Cahen Djuna L, Crolla Rogier MPH, de Wit AW, Bossuyt Patrick MM, Sprangers Mirjam AG, van Bodegraven Ad A, Bemelman Willem A, Eshuis Emma J, van de Laar Arnold, Slot Warner, Eijsbouts Quirijn A, van Ooteghem Nancy AM, van Wagensveld Bart, van den Brande Jan MH, van Geloven Anna AW, Bruin Karien F, Maring John K, Oldenburg Bas, van Hillegersberg Richard, de Jong Dirk J, Bleichrodt Robert, van der Peet Donald L, Dekkers Pascal EP, Goei T Hauwy, Stokkers Pieter CF
Publikováno v:
BMC Surgery, Vol 8, Iss 1, p 15 (2008)
Abstract Background With the availability of infliximab, nowadays recurrent Crohn's disease, defined as disease refractory to immunomodulatory agents that has been treated with steroids, is generally treated with infliximab. Infliximab is an effectiv
Externí odkaz:
https://doaj.org/article/795aff88a447441e8a6f76ab2aa8f6b6
Autor:
Spanier, BW Marcel, Tuynman, Hans ARE, van der Hulst, René WM, Dijkgraaf, Marcel GW, Bruno, Marco J
Publikováno v:
American Journal of Gastroenterology (Springer Nature); Dec2011, Vol. 106 Issue 12, p2183-2188, 6p, 4 Charts